ABSTRACT. The rise in antioxidant enzyme activity in the lungs of late-gestation fetuses is thought to be caused by the preparation of the pulmonary antioxidant system for birth. However, recent data have shown that such a rise also occurs in the livers of late-gestation fetuses. Consequently, this surge cannot solely be ascribed to the preparation of the pulmonary antioxidant system for birth. In this studv we examine the ex~ression of copperlzinc superoxide dismutase (Sodl) and'glutathione perixidase (Gpxl) in various organs of late-gestational mouse fetuses. Furthermore, we compare the expression of these genes in organs of fetuses, neonates, and adult mice. These studies were carried out to investigate whether the change in mRNA levels for these two genes is related to a developmental change in oxidant stress. Our data demonstrate that an increase in both Sod1 and Gpxl mRNA occurs in lungs and livers of late-gestational mouse fetuses. The brain demonstrates an increase in Sod1 expression at or around the time of birth, the kidney shows an elevation in Gpxl mRNA levels, and the heart fails to demonstrate a surge in both Sod1 and Gpxl mRNA levels. Our data show that the liver is the organ with the highest levels of Sod1 and Gpxl mRNA in embryos and neonates (immediately after birth). In the adult, the liver has the highest levels of Sod1 mRNA and the spleen the highest level of Gpxl mRNA. These data suggest that the levels of Sod1 and Gpxl mRNA are unrelated to oxygen consumption and to oxygen tension exposure of individual organs and do not necessarily appear to occur in the lung solely in preparation for birth. The reasons for the increase in antioxidant enzyme(s) mRNA levels in late gestation are more complex and may involve other factors. (Pediatr Res 35: [188] [189] [190] [191] [192] [193] [194] [195] [196] 1994) Abbreviations Sod. su~eroxide dismutase ~o d i , cbpper/zinc superoxide dismutase Gpxl, glutathione peroxidase hydrogen peroxide, and the highly reactive hydroxyl radical, which will interact with macromolecules in their immediate vicinity causing damage to lipids and DNA (I). Cells have developed antioxidant defenses to protect against such noxious moieties. Important are the scavenging enzymes such as Sod (EC 1.15.1.1), Gpxl (EC 1.1 1.1.9). and catalase (EC 1.1 1.1.6). Eukaryotic cells have a secretory or extracellular form of Sod and two kinds of intracellular Sod enzymes: a ubiquitous predominant copper/zinc-containing enzyme (Sod I). which is mainly cytosolic in location (2). and a manganese-containing enzyme (Sod2). which is found in the mitochondria (3). Sod catalyzes the conversion of the superoxide radical to hydrogen peroxide. Hydrogen peroxide in turn is catalyzed to water by Gpxl or catalase (4). Consequently. it is the concerted action of all the antioxidant enzymes that enables the cell to function in an otherwise noxious environment.
The birth of a fetus results in a transition from an hypoxic environment in fctero [Po? 2.66-3.99 kPa (20-30 mm Hg)] to a relatively hyperoxic environment [13.3 kPa (100 mm Hg)] (5). Thus, the birth of a fetus involves a significant oxidative stress that can result in the generation of toxic reactive oxygen species (5). Indeed. numerous studies have demonstrated a surge in the activity of pulmonary antioxidant enzymes in the fetus during late gestational stages (5-10). The reasons for such an increase have been proposed to be the preparation of the pulmonary system for the acute change in oxygen concentration that occurs at birth. However, this increase in the activity of the antioxidant enzymes in late gestation may be the result of other factors. Such a possibility has been suggested by Rickett and Kelly (5). who have shown that a rise in the activity of antioxidant enzymes also occurs in the livers of guinea pig fetuses during late gestation. No data are currently available on the expression of antioxidant enzymes in other organs of late-gestational mammalian fetuses. To gain further insight into the significance of the rise in antioxidant enzyme activity in organs of late-gestational fetuses and neonates and to examine how widespread this phenomenon is, we investigated the expression of the Sod I and Gpx 1 genes in a variety of murine embryonic, fetal. and neonatal organs. Specifically, this study investigated whether a change in mRNA levels for these two genes was related to a developmental change in oxidant stress.
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Each of the organs and tissues was carefully dissected from the mice, ensuring that no contamination from other organs or tissue resulted. Furthermore, individual organs were rinsed in PBS, pH 7.0, several times. These organs were immediately frozen in liquid nitrogen for RNA analysis. These experiments were approved by the Animal Ethics Committee of Monash University.
RNA extraction. Total cellular RNA was extracted according to the method of Chomczynski and Sacchi (12). Twenty-pg aliquots of RNA were lyophilized for Northern analysis, and 20-, lo-, 5-, and 2.5-pg aliquots were used for dot-blot analysis.
Cloning and seqzrencing qfmlirin~ Sod1 cDN4. Total cellular RNA from I-d neonatal murine brains was used for cDNA synthesis in the following reaction: 10 pg of RNA were mixed with 20 pM of an oligo dT,,,, adaptor containing a lVotI restriction site (shown in bold) (5'-[TlI5CGCCGGCGCTTAAGGG-CCC-3'). The RNA plus added oligonucleotide was heated to 65°C and thereafter slowly cooled to 42°C. For the cDNA reaction the following were added and incubated at 42°C for 1 h: 1.0 mM deoxyribonucleoside triphosphate. 50 mM Tris-HCI (pH 8.3). 6 mM MgCI?, 10 mM DTT. 35 IU RNasin, and 20 IU Moloney murine leukemia virus reverse transcriptase. An oligonucleotide (5'-CTTCTCGTCT'AGATCTCTCTG-3') homologous to the most 5' sequence of a murine Sod1 cDNA (13) was synthesized. Two base changes (underlined) were made to create an additional XhuI cloning site (shown in bold). This oligonucleotide. together with the oligo d T I I ) adaptor described above. was used in the polymerase chain reaction to amplify a murine Sod 1 cDNA from the neonatal brain cDNA library generated above. The polymerase chain reaction was performed as follows: 20 pM of each oligonucleotide was added to 0.5 pg cDNA in 10 mM Tris-HCI (pH 8.3). 1.25 mM deoxyribonucleoside triphosphate. 0.1 % Triton-X 100. 1.5 mM MgC12. and 5 IU Taq polymerase (Promega. Madison, WI); 35 cycles of I min at 95°C. 1 min at 65"C, and 2 min at 72°C. The 600-bp polymerase chain reaction product was excised and purified using Geneclean (Bio-I0 I . CA). The purified DNA was restricted with NotI and f i u l and cloned into pGEM-9Zf(-). The nucleotide sequence was determined by the dideoxynucleoside chain-termination method ( 14) using universal forward and reverse primers to sequence from both ends of the insert. The chemical reaction products were electrophoresed on urea/polyacrylamide (30: 1 ) gels. Sequence data were analyzed using PC/Gene Software (IntelliGenetics. Inc., Mountain View. CA).
Northern and dot-blot ana1j:si.s. The techniques used for gel electrophoresis. Northern transfer, and dot-blot analysis have been previously described ( I 1 ). The murine Sod 1 probe (6 13 bp) was released from pGEM-9Zf(-) after restriction with X'huI and NotI. Human catalase (plasmid pCAT10) was obtained from the American Type Culture Collection (Rockville. MD). Murine @-actin and murine Gpxl were gifts from Drs. T. Papas and I. Chambers, respectively. An oligonucleotide homologous to an 18s ribosomal rat sequence (5'-CGGCATGTATTAGCTCTA-GAATTACCACAG-3') was synthesized. Hybridization probes were prepared and labeled as previously described ( 1 1 ). The 18s oligonucleotide was end-labeled using polynucleotide kinase (Promega) and ["PIATP (Amersham. Buckinghamshire. UK). Northern filters were prehybridized. and they were hybridized with Sod I . Gpx I . and @-actin probes as previously described (1 1). The 18s ribosomal oligonucleotide probe was hybridized in molar excess. These filters were washed in 0.1 x sodium chloride, sodium phosphate, EDTA at 65°C for 15 min. Prehybridization conditions and hybridization with an 18s oligonucleotide were as follows: prehybridization was for 2-4 h in 50% formamide, 2.5 x sodium chloride, sodium citrate. 5 x Denhardt's solution, 25 mM H2P04 (pH 7.4), 0.05 mg/mL salmon sperm DNA, and 0.05% SDS, and hybridization occurred for 14-16 h at 37°C in the same solution. These filters were washed in 1 x sodium chloride, sodium phosphate. EDTA, 0.1% SDS at 40°C for 15 min. Autoradiography was performed using intensifying screens at -70°C and Fuji x-ray RX medical film.
Northern blots were first hybridized with Sodl. the probe removed ( I I ). and then sequentially hybridized with the Gpxl probe, the d-actin probe, and the 18s oligonucleotide. Before rehybridization of filters, autoradiography was carried out to confirm that no residual signal remained. The transcript size(s) for each of the genes was confirmed on Northern blots relative to 28s and 18s RNA and was also approximated by the use of size markers as previously described ( l 1 ). Northern-blot and dotblot autoradiograms were scanned (for quantitation) using an Ultroscan XL LKB densitometer (Bromma, Sweden). Laser densitometry for all of the autoradiograms were conducted on lighter exposures of the filters where the signal density or radioactivity was still in the linear range. Care was also taken to pass the scanning beam in a path where nonspecific signals were not present and thus did not interfere with the quantitation. Sodl and Gpxl expression was corrected for RNA loading and is shown relative to @-actin and 18s ribosomal RNA. The mRNA levels of each gene are expressed as a ratio of the area under the curve for the signal of that particular gene over the area under the curve for B-actin, and this ratio was corrected relative to 18s ribosomal RNA to correct for slight differences in RNA loading between different lanes. All the data in this study were similar when corrected relative to @-actin as compared with that corrected relative to @-actin and subsequently to 18s ribosomal RNA. It is also important to note that rehybridization of the filters with another housekeeping gene (GAPDH) showed that the levels of @-actin and GAPDH followed one another extremely closely, and both were significantly different from that of 18s ribosomal RNA (data not shown). One lane on each filter was loaded with 15-d embryo total RNA-this served as a control and facilitated comparison across different filters by normalization of each filter relative to this sample when required.
Tissue preparation and mzj,tnaric ussaj:~. Approximately 10 organs were pooled for each time point. Tissues were homogenized (0.5 g/mL wet wt) in 65 mM phosphate buffer containing I% Triton-X 100 and centrifuged at 105 000 x ,q for 1 h. The supernatant was used to measure both Sod 1 and Gpx I activity.
Sod activity was assayed according to Elroy-Stein ct al. (15). To measure total Sod activity, we added 250 pL of supernatant to 25 pL of xanthine (1.142 mg/mL), 25 pL of hydroxylammonium chloride, 125 pL of H20, and 75 pL of xanthine oxidase (0.1 IU/mL). The mixture was incubated at 25°C for 20 min. Thereafter. 0.5 mL of sulfonilic acid (3.3 mg/mL) and 0.5 mL of a-naphthylamine ( 1 ng/mL) were added and further incubated at room temperature for 20 min. The absorbance was measured at 530 nm. The addition of 125 pL of KCN (4 mM) in place of HzO in the above reaction specifically inhibits Sodl activity. Thus subtraction of the Sod activity remaining after KCN treatment (i.e. Sod2) from the total Sod activity gives the Sod I activity of the sample. Sod I activity is expressed as IU/mg tissue.
Gpxl activity was assayed according to the method of Lawrence and Burk (16). Briefly. 800 pL of the following solution was prepared for each sample and incubated at room temperature for 5 min: 62.5 mM potassium phosphate buffer (pH 7.0). 1 mM EDTA. I mM NaN3, 0.2 mM @-NADPH. 1 IU glutathione reductase, and 0.3 1 mM reduced glutathione. Thereafter, 0.1 mL of 0.25 mM H20z was added and further incubated at room temperature for 5 min. and the reaction was commenced by the addition of 0.1 mL of supernatant. The change in absorbance was measured at 340 nm for 5 min. Gpxl activity is expressed as pmol NADPH oxidized/min/mg tissue.
RESULTS
Cloning and Sequencing qj'hflirine c.DN.4 ii,r Sodl. The Sod 1 cDNA clone isolated contains 53 bp 5' from the ATG start site. 462 bp coding sequence and 75 bp 3' of the stop codon. A coding region of 462 bp is consistent with other published sequences for murine Sod1 cDNA ( 1 3. 17). Our sequence is identical to that of Bewley ( 17). including the atypical polyadenylation sequence (ATTAAA), with the exception that they have an additional A inserted at position 486 and that we find a T instead of an A at position 499. Our cDNA clone is identical to that of Getzoff et al. (13) with regard to these two differences. However, we have one difference in our sequence compared with Getzoff er al. ( 1 3). namely, we do not find a G inserted between position 470 and 47 1. In this instance our sequence is the same as that of Bewley (17). These differences in our sequence from that of Bewley (17) and Getzoff et al. (13) do not affect the amino acid sequence of the clone because they occur in the 3'-untranslated region. Northern analysis of murine tissue showed that our cDNA probe detected one transcript of approximately 0.7kb as expected ( 18).
Developmental E.~pression of'Sodl and G p .~l in Orguns and Amnion of Mouse Fetuse.~. L~mg. Sodl and Gpxl expression increases sharply before or around the time of birth (Figs. I and  20) . This increase is manifested by the 5-and 7-fold higher levels of Sodl and Gpxl mRNA, respectively, in the lungs of I-d neonatal mice as compared with those of 19-d fetal mice. Thereafter, in 7-d neonatal mice, a decline in the mRNA levels for Sod 1 and Gpx 1 occur. The profiles of Sod 1 and Gpx 1 mRNA are similar in late gestation and neonatal development. These profiles for Sod l and Gpx l mRNA were similar irrespective of whether the Sod 1 and Gpx I mRNA levels were expressed relative to @-actin or p-actin and 18s ribosomal RNA or 18s ribosomal RNA only (data not shown). However, in the liver the data is significantly different when expressed relative to 8-actin (or GAPDH) or 18s ribosomal RNA (see below).
The mRNA levels for Sod 1 and Gpx l were also examined at time periods earlier than d 17 (viz. d 14 to 16). Curiously. the Sod I mRNA levels were relatively high in these earlier periods (Fig. 3) . Indeed, the Sod I mRNA levels in 15-d lungs were higher than at any other time in the gestational and neonatal periods. Gpx I mRNA levels were also higher in 15-d and 16-d lungs than at any other stage in development.
Liver. Sodl and Gpx 1 expression relative to b-actin increases from d 17 through d 19 (approximately 20-and 3-fold increase, respectively) ( Figs. 1 and 2b) . Thereafter, Sod1 and Gpx 1 mRNA levels show a marked decline at or around the time of birth. This decline is still evident on d 7 of neonatal life. The profiles of Sodl and Gpxl mRNA levels in the livers of mice at various stages of development are also similar.
With regard to the expression of Sod l and Gpx l relative to 18s ribosomal RNA, if the data are analyzed in this manner. a different pattern of expression is obtained from that described in the preceding paragraph. The levels of Sod 1 and Gpx I mRNA are greatly elevated between d 19 of gestation and the first d of neonatal life (Fig. 4) 
With regard to Sod l and Gpx l activity, this experiment was undertaken for two reasons: I ) to investigate the correlation of mRNA levels for Sodl and Gpxl with enzyme activity: and thereby 2 ) to determine which of the two methods of mRNA analysis above was more accurate. especially because the liver was the only organ investigated that showed a difference in Sod I and Gpxl mRNA profiles. This was dependent on whether the data was corrected relative to 18s ribosomal RNA only or relative to a housekeeping gene (o-actin or GAPDH) and 18s ribosomal RNA (or to a housekeeping gene only because no differences in the patterns for 8-actin/GAPDH or 18s ribosomal RNA were obtained).
The enzyme activity for Sod I and Gpx I was similar (Fig. 5a ) to the mRNA profiles for these two enzymes as demonstrated in the earlier discussion regarding expression relative to @-actin [i.c. the data corrected relative to @-actin and 18s ribosomal RNA (Fig. 2h) l (or either 8-actin or GAPDH alone, data not shown). These data demonstrate that the activity of Sod I and Gpx 1 are elevated in late gestation at or around the time of birth. Furthermore, the mRNA profile for Sod1 and Gpxl correlate well with the activity for these two enzymes in the time periods investigated.
Brain. With regard to mRNA profiles, an increase in Sod1 mRNA, and not Gpxl mRNA. occurs in the brain of lategestation and neonatal mouse fetuses (Figs. 6 and 2c ). An approximately 3-fold increase in Sod 1 mRNA levels occurs between d 17 and d 19 of gestation. Sod1 mRNA levels continue to rise into the neonatal stages of development (a further 2-fold increase occurs). Gpxl mRNA levels, on the other hand, do not demonstrate a similar increase (if at all) in mRNA levels in late gestation. These levels remain relatively unchanged during late development and after birth.
The activity of Sod1 and Gpxl (Fig. 5b) correlated well with the mRNA profiles of the two genes (Fig. 2c) . Sod1 activity was higher on d 19 of gestation as compared with earlier periods of development, and the Sod1 activity was even higher in 7-d neonatal brains. G p x l activity, like that of the mRNA levels. Figure I is corrected relative to 18s ribosomal RNA. Note: The liver is the only organ that showed a difference in Sodl and Gpxl mRNA profiles when the data were corrected relative to (j-actin (or GAPDH) and 18s ribosomal RNA as compared with that relative to 18s only.
was relatively unchanged in late development and after birth. These data, together with those for the liver, provide further evidence for a good correlation between mRNA profiles and enzyme activity. Consequently. mRNA levels only were subsequently studied. Heart. Sod 1 and Gpx 1 mRNA levels fail to demonstrate a late fetal surge in the heart (Figs. 1 and 2e ). Sod1 mRNA levels are essentially unchanged throughout this period and into the first day of neonatal development. However, a sharp rise (a Cfold increase) in Sod1 mRNA levels occurs in the heart of 7-d neonatal mice as compared with that of I-d neonatal mice.
Gpxl, on the other hand, is expressed at high levels in 17-d fetuses, and these levels decline on d 18 and 19. Thereafter, Gpx I demonstrates a modest (I .2-fold) increase in mRNA levels just before or at birth. A further 2-fold increase in Gpx I mRNA levels occurs in 7 4 neonatal mice as compared with I -d neonatal mice.
Stomach. Sodl mRNA levels, and not those of Gpx I, show an elevation at or around the time of birth. A steady increase in Sod1 expression occurs before (approximately 6-fold increase) and after birth (a further 1.6-fold increase) (Figs. 1 and 2f) . Comparison of Sod1 and Gpxl Expression in Organs of Different Aged Fetuses. Having compared the expression of Sodl and Gpxl mRNA levels in individual organs of fetuses on different days of late-gestational development, we compared the expression of Sodl and Gpxl in the different organs of fetal, neonatal, and adult mice at specific stages of development. These investigations were conducted with a view of gaining further insight into the reasons for the modulations of Sodl and Gpxl mRNA levels.
Day 14 fetuses. The liver expresses the highest levels of both Sod l and Gpx l in 14-d murine fetuses (Figs. 8 and 9a ). The descending order for Sodl expression is as follows: liver > heart > kidney > brain > intestine > stomach > lung. The order for Gpxl expression is as follows: liver > kidney > heart > lung > brain > intestine > stomach. (Figs. 8 and 9c) . Sod 1 mRNA levels in the liver are approximately 1 .$fold greater than the kidney, which expressed the second highest amount of Sodl. The level of Sodl in the heart is similar to that in the kidney. The heart is followed by (in descending order of expression) stomach. lung. brain. and intestine. The d I neonatal liver also has the greatest amount of Gpxl mRNA. This amount is approximately 2-fold greater than the heart. which is followed by the kidney. lung. stomach, intestine, and brain.
l a Days
DUJ. 7 nconutrJ.s. The quantitative pattern of Sodl and Gpxl expression changes in the organs of 7-d neonatal mice (Figs. 8  and 9 4 . At this stage of development. the organ with the highest mRNA levels for Sod1 is the heart. followed by thymus > brain > liver > lung > stomach > spleen > kidney. The organ with the highest mRNA for Gpxl is the spleen. The levels of Gpxl mRNA in the spleen are approximately 3-fold higher than those of the liver (the organ with the second highest level of Gpxl mRNA). The liver is followed by the heart > thymus > lung > stomach > brain > kidney.
:idlcIr or<yuns At this stage of development, the liver is the organ with the highest levels of Sod1 mRNA among the seven adult organs studied (Figs. 8 and 90 ). This level is approximately ?-fold higher than that of the spleen. which is the organ with the second highest levels of Sodl mRNA. The other organs have relatively similar levels of Sod 1 mRNA with the order as follows: lung > kidney > brain > heart > ovary. The adult spleen is the organ with the highest levels of Gpxl mRNA. This level is approximately 7.5-fold greater than the level of Gpx I mRNA seen in the liver (the organ with the second highest level of Gpx I mRNA). The remaining organs follow as listed: kidney (with Day 16 fetuses. The liver is still the organ expressing the highest levels of Sod1 mRNA in 16-d murine fetuses (Figs. 8 and 9h) . The order of Sod I expression in organs of 16-d murine fetuses is as follows: liver > intestine > heart > kidney > lung > stomach > brain. The order of Gpx1 mRNA levels in these fetuses is as follows: heart > liver > lung > kidney > intestine > brain > stomach.
Day 1 neonates. The liver is also the organ with the highest DISCUSSION We have shown the following in this study: I ) Sod l and Gpx I mRNA levels are quantitatively regulated in a temporal and tissue-specific manner during later fetal development. 2 ) a surge in expression of both Sod1 and Gpx1 mRNA levels occurs just before or at birth in the lung and stomach and in late gestation in the liver (both mRNA levels and enzyme activity): 3) an elevation in Sodl occurs before or at birth in the brain: 4 ) the kidney shows an elevation in Gpx I mRNA levels at or around the time of birth: 5 ) the heart does not demonstrate a surge at birth in the expression of the antioxidant enzymes studied: 6 ) the expression of Sod 1 and Gpx 1 mRNA progressively increases in the amnion until d 14 and d 13 of gestation. respectively. after which a decline occurs in expression of these genes: 7) of the organs studied, the liver is the one with the highest levels of both Sod 1 and Gpx 1 mRNA levels during murine embryogenesis and immediately after birth: it is also the organ with the highest expression of Sod1 mRNA in the adult; and 8) the spleen is the organ with the highest levels of Gpxl mRNA in 7-d neonatal and adult mice. These findings are relevant to an analysis of the reason for the surge in antioxidant enzymes in late gestation o r at birth, and to the levels of antioxidant gene product in different organs of embryonic, neonatal, and adult mice.
Previous studies have mainly focused on the activity of antioxidant enzymes in the lung in late gestation or at birth. These studies (5-9. 19) have demonstrated that in a variety of animal species (guinea pig, rabbit, hamster, and rat) a surge in pulmonary antioxidant enzyme activity occurs in late gestation before birth. These findings have been ascribed to the preparation of the pulmonary antioxidant system, in a manner analogous to the surfactant system (5). for the process of birth. During the birth process the fetus will move from a relatively hypoxic environment to an hyperoxic environment where an approximately 5-fold elevation in oxygen concentration occurs (5). Thus, the surge in antioxidant enzyme expression may be beneficial in protecting the newborn from oxygen toxicity, especially because a n equivalent increase in inspiratory oxygen concentration is lethal to adults (20).
It cannot necessarily be assumed, however, that the surge in antioxidant expression that occurs in late fetal development in other animal species occurs in the mouse. It has been reported that such a surge fails to occur in the human lung (2 1). Furthermore, we have been unable to find data examining the expression of Sod l and Gpx l in late-gestational mouse fetuses. Only one study has examined the embryonic expression of Sod1 and Gpx 1 in the mouse liver and the remaining carcass (22). These workers report an increase in the expression of Sod1 and Gpxl in the liver and remaining carcass during development. They have not. however. studied the expression of antioxidant enzymes in other individual organs. Thus. our data of increasing Sod1 and Gpx I mRNA levels in the mouse lung at or just before birth demonstrates that the mouse is similar in this regard to other animal species. Furthermore. our data would appear to support the hypothesis that the pulmonary antioxidant system undergoes a preparation for birth. However, the process of birth cannot be the sole reason for the surge in antioxidant mRNA levels because we find that during organogenesis (d 14-16) the mRNA levels for Sodl are even higher than those at or around the time of birth. Nevertheless. ifthe transition from an hypoxic to hyperoxic environment is a trigger for the surge in the expression of lung antioxidant enzymes during late fetal development. then this surge should occur in all aerobic organisms where such a transition occurs. In this context. it remains to be explained why such a surge in antioxidant enzymes fails to occur in human fetuses. This explanation is especially important because it has been proposed that the failure to detoxify reactive oxygen species might be related to aspects of the oxidative-induced morbidity and mortality (e.g. bronchopulmonary dysplasia) that occurs in preterm human infants (23).
It has also been argued by others that the surge in expression of antioxidant enzymes in organs of late-gestation fetuses cannot solely be assigned to the preparation of the pulmonary antioxidant system for birth (5). This proposal was based on the finding that a similar surge in the expression of antioxidant enzymes also occurs in the livers of late-gestation guinea pig fetuses (5). The liver. unlike the lung, is not directly exposed to higher oxygen concentrations at birth. Our data in this study confirm and extend the finding of Rickett and Kelly (5) by showing that the surge in the levels of both Sod I and Gpx 1 occurs in the livers of mouse fetuses in late gestation. albeit that the levels for both these enzymes decline after birth in the early neonatal period. It may be that the elevation of expression of antioxidant enzymes in the liver, and the finding that the expression of the antioxidant enzymes is relatively high in adult livers. is related to the rate of metabolism of the organ rather than to the concentration of oxygen pcr sc. Higher rates of metabolism may result in the generation of reactive oxygen species. It is also interesting that the expression of Sod I and Gpx 1 increases in the amnion during the period of organogenesis in the mouse. The amnion is a membrane that surrounds the fetus. Consequently. the elevation of expression of antioxidant enzymes in both the liver and the amnion may afford protection against the generation of reactive oxygen species in the maternal compartment.
The extension of studies on the expression of antioxidant enzymes to other organs may be useful for evaluating the purpose of the surge in antioxidant expression in organ(s) of late-gestation fetuses. The data in this study demonstrate that the elevation in expression of both Sod1 and Gpx 1 antioxidant enzymes occurs in the liver, lung, and stomach. An elevation in Sod 1 expression, but not Gpx I , occurs in the brain of fetuses in late gestation. at birth, or both. However, the heart fails to show an appreciable elevation of both Sod 1 and Gpx 1 expression in late gestation or at birth. Yet the oxygen consumption of the heart in fetal lamb development during late gestation is far greater than that of other organs (8.0 mL/100 g of tissue). Indeed, the order of oxygen consumption by organs in late gestation lamb fetuses is heart (8.0 mL/100 g) > brain (4.0 mL/100 g) = liver > kidney (2.6 mL/100 g) > lung (0.6 mL/100 g) > intestine (0.4 mL/100 g) = skin, bone, and muscle (24). Thus, the data suggest that the increase in expression of antioxidant enzymes in late gestation or at birth in organs of the mouse may not correlate with the
